Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

Under Australia's Pharmaceutical Benefits Scheme (PBS), soon many of the rare diseases and their treatments are set to become cheaper.

21 Mar 2019

New research opens possibility of using sperm taken from testicles to overcome infertility

Scientists have found that sperm DNA from the testicles of many infertile men is as good as that of ejaculated sperm of fertile men. This may explain a major cause of male infertility and opens the possibility of using sperm taken directly from the testicles of these men; to overcome their infertility

15 Mar 2019

Cell therapy may be alternative strategy for treatment of chronic kidney disease

Wake Forest Institute for Regenerative Medicine scientists are working on a promising approach for treatment of chronic kidney disease - regeneration of damaged tissues using therapeutic cells.

15 Mar 2019

Long-awaited structure offers new insights into rejection of transplanted organs

Rejection of any kind is always hard to deal with, but when one's body rejects a precious organ transplant, the consequences can be devastating. Professor A. Vathsala, Co-director of the National University Centre for Organ Transplantation at the National University Hospital and Professor of Medicine, shared that between 30% to 40% of kidney transplants are lost over time to rejection.

15 Mar 2019

PNAS publishes results of pilot study for early detection of liver cancer

Today, Proceedings of the National Academy of Sciences published the results of a pilot study for early detection of liver cancer in a cohort of HBV carriers, who are at risk for developing this disease.

13 Mar 2019

New risk model can predict survival of non-metastatic prostate cancer patients

A new risk model, easily accessible on a web interface, can predict the survival of non-metastatic prostate cancer patients, as well as the effect of different treatment approaches on survival.

13 Mar 2019

Huron Digital Pathology to unveil new ‘Scan Index Search’ platform at USCAP 2019

Huron debuts its new ‘Scan Index Search’ platform, connecting pathologists, researchers and educators with the expertise of their colleagues.

From Huron Digital Pathology 13 Mar 2019

Researchers develop 'snap freezing' apparatus to cool biopsy even faster

For rapid freezing of a biopsy taken from a patient, for cancer research for example, the standard procedure is using liquid nitrogen.

7 Mar 2019

Beckman Coulter Life Sciences and Apostle announce exclusive liquid biopsy partnership

Launch of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company.

From Beckman Coulter Life Sciences - Automation and Genomics 4 Mar 2019

Discovery paves the way for simple blood test to detect early stages of NAFLD

One in four people in Western and Asian societies develop a build-up of fat in the liver as a result of an unhealthy diet. This disease - referred to as non-alcoholic fatty liver disease (NAFLD) - causes no symptoms initially but can develop into end-stage liver cirrhosis with limited treatment options.

1 Mar 2019

New mobile skin bioprinting system to treat large wounds or burns

Imagine a day when a bioprinter filled with a patient's own cells can be wheeled right to the bedside to treat large wounds or burns by printing skin, layer by layer, to begin the healing process. That day is not far off.

28 Feb 2019

Newly discovered drug targets could pave way for esophageal cancer therapeutics

Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma, the most common esophageal malignancy in the United States, according to new research out of Case Western Reserve University School of Medicine.

28 Feb 2019

New microfluidic device can isolate individual cancer cells from blood samples

Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples. The microfluidic device works by separating the various cell types found in blood by their size.

26 Feb 2019

New form of hereditary osteoporosis identified

A research group headed by Professor Outi Mäkitie, Unviersity of Helsinki, identified in families with childhood-onset osteoporosis disease-causing mutations in a gene that had previously not been connected with the skeletal system or osteoporosis.

25 Feb 2019

Mayo clinic researchers discuss local case studies of leprosy

Leprosy has a history that has spanned centuries and societies across the globe. Yet, it continues to be a problem -- even in the modern era.

21 Feb 2019

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

20 Feb 2019

Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad's Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry's first digital PCR products to receive U.S. Food and Drug Administration clearance.

15 Feb 2019

Blood-based liquid biopsies can accurately track cancer treatment responses

Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer treatment responses by measuring circulating tumor DNA (ctDNA) during immunotherapy and related treatments.

14 Feb 2019

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer.

14 Feb 2019

Biopsy News and Research

Further Reading

City of Hope exhibits current studies and data on cancer therapies at AACR

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

New research opens possibility of using sperm taken from testicles to overcome infertility

Cell therapy may be alternative strategy for treatment of chronic kidney disease

Long-awaited structure offers new insights into rejection of transplanted organs

PNAS publishes results of pilot study for early detection of liver cancer

New risk model can predict survival of non-metastatic prostate cancer patients

Huron Digital Pathology to unveil new ‘Scan Index Search’ platform at USCAP 2019

Researchers develop 'snap freezing' apparatus to cool biopsy even faster

Beckman Coulter Life Sciences and Apostle announce exclusive liquid biopsy partnership

Discovery paves the way for simple blood test to detect early stages of NAFLD

New mobile skin bioprinting system to treat large wounds or burns

Newly discovered drug targets could pave way for esophageal cancer therapeutics

New microfluidic device can isolate individual cancer cells from blood samples

New form of hereditary osteoporosis identified

Mayo clinic researchers discuss local case studies of leprosy

New screening method could catch organ rejection much earlier without a biopsy needle

Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients

Blood-based liquid biopsies can accurately track cancer treatment responses

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News